Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/1064
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTalibjanova, Malika Khusanovna-
dc.date.accessioned2025-03-17T05:16:14Z-
dc.date.available2025-03-17T05:16:14Z-
dc.date.issued2024-12-12-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/1064-
dc.description.abstractIn the context of the COVID-19 pandemic, studying the peculiarities of organ and system damage in patients is of utmost importance. Currently, COVID-19 is considered a systemic disease that disrupts the immune system and primarily affects the lungs, as well as the heart, kidneys, and intestines. Severe cases are characterized by hyperimmune inflammation, renin-angiotensin-aldosterone system imbalance, endothelial dysfunction, and specific vasculopathies such as thrombotic microangiopathy and intravascular coagulopathy. This condition, referred to by some experts as a thromboinflammatory process or COVID-19- associated coagulopathy, represents a critical area of researchen_US
dc.language.isoenen_US
dc.publisherInternational Conference on Medical Science, Medicine and Public Healthen_US
dc.titleFEATURES OF LIVER DAMAGE IN COVID-19 INFECTIONen_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
1- хорижий тезис.pdf687.01 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.